Press release
2025-2034 Ankylosing Spondylitis Market Evolution: Disruptions, Innovations, and Untapped Opportunities
Ankylosing Spondylitis
What Is the Expected CAGR for the Ankylosing Spondylitis Market Through 2025?
In recent times, there has been a robust growth in the size of the ankylosing spondylitis market. From $5.9 billion in 2024, it is projected to escalate to $6.36 billion in 2025, marking a compound annual growth rate (CAGR) of 7.8%. The significant expansion in the historic period can be credited to factors such as the discovery of hla-b27, advancement in biologic treatments, novel pain management methodologies, patient advocacy and awareness, NSAIDS, and disease-modifying drugs.
What's the Projected Size of the Global Ankylosing Spondylitis Market by 2029?
In the coming years, a significant increase in growth is forecasted for the ankylosing spondylitis market. The market value is projected to rise to $8.71 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. This expected growth during the forecasted period can be linked to factors such as the implementation of personalized medicine, the development of novel biologics, early intervention and screening, lifestyle and diet modifications, and the use of telemedicine along with remote monitoring. In addition, the foreseeable period will witness trends such as the availability of biosimilars, targeted pain therapies, the importance of patient-reported outcomes (pros), community support programs, and exploration of regenerative medicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report
Top Growth Drivers in the Ankylosing Spondylitis Industry: What's Accelerating the Market?
The surge in the elderly population is predicted to spur the expansion of the ankylosing spondylitis market. The term 'geriatric population' denotes a change in population age structure, leading to a higher percentage of older adults. This age demographic shift has bolstered both the numbers and the proportion of those aged over 60. Treatments and medications for ankylosing spondylitis support enhanced movement and pain management in the elderly with this condition. For example, in January 2023, the United Nations Department of Economic and Social Affairs (UN DESA), a department within the UN Secretariat based in the US, forecasted that the worldwide count of individuals aged 65 and over will more than double, soaring from 761 million in 2021 to 1.6 billion by 2050. Consequently, the rising elderly population is augmenting the ankylosing spondylitis market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp
What Trends Will Shape the Ankylosing Spondylitis Market Through 2029 and Beyond?
The improvement of therapeutic solutions is becoming a notable trend in the ankylosing spondylitis market. To maintain their market position, companies are developing new treatment options for ankylosing spondylitis. For example, in April 2022, US biopharmaceutical company AbbVie Inc. announced the U.S. Food and Drug Administration (FDA) has approved its product RINVOQ for treating adults with active ankylosing spondylitis (AS). This offers an additional oral therapy for patients who have not responded well to TNF blockers, displaying marked improvements in symptoms like back pain and physical capabilities. The fast effectiveness and safety observed in clinical trials make this a noteworthy advancement for managing the chronic inflammatory condition, thus broadening the range of available treatment options for patients.
What Are the Main Segments in the Ankylosing Spondylitis Market?
The ankylosing spondylitis market covered in this report is segmented -
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route Of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users
Subsegments:
1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs
3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors
4) By Steroids: Oral Steroids, Injectable Steroids
5) By Physical Therapies: Physiotherapy, Exercise Programs
6) By Surgery: Joint Replacement Surgery, Spinal Surgery
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp
Which Top Companies are Driving Growth in the Ankylosing Spondylitis Market?
Major companies operating in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.
Which Regions Will Dominate the Ankylosing Spondylitis Market Through 2029?
North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Ankylosing Spondylitis Market Evolution: Disruptions, Innovations, and Untapped Opportunities here
News-ID: 4097552 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Ankylosing
Ankylosing Spondylitis Medication Market Size And Global Industry Forecast 2034
"As of 2024, the global ankylosing spondylitis (AS) medication market is valued at approximately $5 billion, driven by an increasing prevalence of the condition and a growing awareness of treatment options. The market is projected to reach roughly $9 billion by 2034, reflecting a robust growth trajectory over the next decade. The anticipated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at around…
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate?
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638
Introduction:
The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively.
Unveiling Ankylosing…
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.…
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate the…
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen…
